ArticleGenes & diseases2026

Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma.

Shenghua Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.